ZLAB.NASDAQZai Lab LTD

Form 4: Zai Lab Executive Harald Reinhart Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Harald Reinhart, a Zai Lab executive, reports the acquisition and disposal of American Depositary Shares (ADS) related to vesting Restricted Share Units (RSUs).

Summary

  • On April 3, 2024, Harald Reinhart, President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases at Zai Lab, acquired 5,270 American Depositary Shares (ADS) at $15.90 each upon vesting of Restricted Share Units (RSUs).
  • On April 4, 2024, Reinhart disposed of 2,105 ADSs at $15.673 each to cover taxes associated with the vesting of the RSUs.
  • Following these transactions, Reinhart directly owns 51,800 ADSs.
  • The RSUs vest in equal annual installments over four years, starting on April 3, 2024.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard disclosure of insider trading activity related to compensation.

Future Outlook

The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their alignment with shareholder interests.

Key Dates

DateDescription
04/03/2024Date of earliest transaction; acquisition of 5,270 ADSs upon vesting of RSUs; start of RSU vesting period.
04/04/2024Disposal of 2,105 ADSs to cover taxes.
04/05/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.